Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) had its price objective decreased by JMP Securities from $23.00 to $14.00 in a research note issued to investors on Thursday morning,Benzinga ...

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) shares reached a new 52-week low during trading on Friday after JMP Securities lowered their price target on the stock from $23.00 to $14 ...

The ADC in question, dubbed MRG007, has shown “robust antitumor activity in preclinical models of GI cancers and a favorable ... via in-licensing deals. The biotech’s lead asset, furmonertinib ...

A live webcast of the fireside chat can be accessed through the Investors & Media section of the Company’s website at https://investors.vaxcyte.com. A replay of the webcast will be available for ...

It was an extremely busy week in the biotech sector, with several companies ... The acquisition adds to GSK’s growing portfolio in gastrointestinal (GI) cancers, including ongoing trials with ...

Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today shared details about the data it will present at the ASCO GI ...

“In relapsed anal cancer, the efficacy signal that was initially reported continues to outperform historical control trials with the inclusion of additional patients,” said Thomas Heineman, M.D., Ph.D ...

No new safety signals were identified. Price Action: PFE stock is up 2.76% at $26.81 at the last check on Monday.

CAMBRIDGE, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (“Walden”), a private, venture-backed biotechnology company advancing disease-modifying therapies to transform the ...

The Company will host a live webinar presentation with Chris Cargill, President and CEO, Hironoshin Nomura, CFO, Matt Barnes, President of Nxera Pharma UK and Head of UK R&D and Makoto Sugita, ...